Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan

被引：0
|
作者：
Shigeaki Ohno
Itsuro Umebayashi
Miyuki Matsukawa
Takashi Goto
Toshiro Yano
机构：
[1] Hokkaido University,Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine
[2] Aishin Memorial Hospital,Department of Ophthalmology
[3] Mitsubishi Tanabe Pharma Corporation,Ikuyaku. Integrated Value Development Division
[4] Mitsubishi Tanabe Pharma Corporation,Ikuyaku. Integrated Value Development Division
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Behçet’s disease; Uveoretinitis; Biological therapies; Infliximab; Postmarketing surveillance; Safety; Efficacy; Associated factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behcet's disease: a large-scale, long-term postmarketing surveillance in Japan
    Ohno, Shigeaki
    Umebayashi, Itsuro
    Matsukawa, Miyuki
    Goto, Takashi
    Yano, Toshiro
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [2] Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease
    Abu El-Asrar A.M.
    Abboud E.B.
    Aldibhi H.
    Al-Arfaj A.
    International Ophthalmology, 2005, 26 (3) : 83 - 92
  • [3] Long-Term Infliximab Treatment for Behçet's Disease
    Mitsuko Takamoto
    Toshikatsu Kaburaki
    Jiro Numaga
    Yujiro Fujino
    Hidetoshi Kawashima
    Japanese Journal of Ophthalmology, 2007, 51 : 239 - 240
  • [4] Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behcet's disease
    Katsuyama, Atsuko
    Kusuhara, Sentaro
    Nishisho, Ryuto
    Matsumiya, Wataru
    Azumi, Atsushi
    Nakamura, Makoto
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 521 - 527
  • [5] Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease
    Antonio Vitale
    Giacomo Emmi
    Giuseppe Lopalco
    Claudia Fabiani
    Stefano Gentileschi
    Elena Silvestri
    Di Scala Gerardo
    Florenzo Iannone
    Bruno Frediani
    Mauro Galeazzi
    Giovanni Lapadula
    Donato Rigante
    Luca Cantarini
    Clinical Rheumatology, 2017, 36 : 2063 - 2069
  • [6] Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease
    Antonio Vitale
    Giacomo Emmi
    Giuseppe Lopalco
    Claudia Fabiani
    Stefano Gentileschi
    Elena Silvestri
    Gerardo Di Scala
    Florenzo Iannone
    Bruno Frediani
    Mauro Galeazzi
    Giovanni Lapadula
    Donato Rigante
    Luca Cantarini
    Clinical Rheumatology, 2019, 38 : 267 - 267
  • [7] Long-term data on efficacy and safety of adalimumab in Beh?et's disease
    van der Houwen, T. B.
    Humer, B.
    Missotten, T. O.
    Thiadens, A. A. H. J.
    van Hagen, P. M.
    van Laar, J. A. M.
    CLINICAL IMMUNOLOGY, 2023, 247
  • [8] Long-term efficacy of infliximab on background vascular leakage in patients with Behçet’s disease
    H Keino
    A A Okada
    T Watanabe
    W Taki
    Eye, 2014, 28 : 1100 - 1106
  • [9] Long-term efficacy and safety of infliximab in refractory uveitis of Behcet's disease
    Laura, N
    Carlotta, N
    Giampaolo, G
    Ivo, L
    Maurizio, B
    Carlo, S
    Luca, C
    Ignazio, O
    Fabrizio, C
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 262 - 262
  • [10] Long-Term Efficacy and Safety of Infliximab in the Treatment of Behcet's Disease
    Capella, Maria Jose
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (03) : 198 - 202
12345